Utilization of Marginal Lung Donors With Low PaO


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
06 2020
Historique:
received: 14 02 2019
revised: 25 11 2019
accepted: 23 12 2019
pubmed: 19 2 2020
medline: 7 8 2020
entrez: 19 2 2020
Statut: ppublish

Résumé

Lungs of donors with high body mass index (BMI) have more atelectasis and a lower PaO From February 2016 to December 2018, 336 lung transplants were performed at Cleveland Clinic. Of these, 58 met criteria for our aggressive approach to donors with a P/F ratio of less than 300 mm Hg at offer and BMI of 25 kg/m Of the 58 donors, 33 were converted to straight lung transplantation because they demonstrated significant improvement in the P/F ratio after lung recruitment compared with the P/F ratio at lung offer (median, 278 versus 420 mm Hg; P < .01). Seventeen lungs with a persistently low P/F ratio underwent EVLP, 8 of which were transplanted. There was no significant difference in primary graft dysfunction grade 3 at 72 hours (n = 3 of 41 [7.5%] versus 31 of 247 [13%]; P = .79) or in 30-day survival (100% versus 97%; P = .60) between low P/F-high BMI and standard groups. These data suggest that atelectasis in high-BMI donors contributes to P/F ratios less than 300 mm Hg and that intraoperative lung recruitment or EVLP can allow the use of lungs from these donors with good outcomes.

Sections du résumé

BACKGROUND
Lungs of donors with high body mass index (BMI) have more atelectasis and a lower PaO
METHODS
From February 2016 to December 2018, 336 lung transplants were performed at Cleveland Clinic. Of these, 58 met criteria for our aggressive approach to donors with a P/F ratio of less than 300 mm Hg at offer and BMI of 25 kg/m
RESULTS
Of the 58 donors, 33 were converted to straight lung transplantation because they demonstrated significant improvement in the P/F ratio after lung recruitment compared with the P/F ratio at lung offer (median, 278 versus 420 mm Hg; P < .01). Seventeen lungs with a persistently low P/F ratio underwent EVLP, 8 of which were transplanted. There was no significant difference in primary graft dysfunction grade 3 at 72 hours (n = 3 of 41 [7.5%] versus 31 of 247 [13%]; P = .79) or in 30-day survival (100% versus 97%; P = .60) between low P/F-high BMI and standard groups.
CONCLUSIONS
These data suggest that atelectasis in high-BMI donors contributes to P/F ratios less than 300 mm Hg and that intraoperative lung recruitment or EVLP can allow the use of lungs from these donors with good outcomes.

Identifiants

pubmed: 32067990
pii: S0003-4975(20)30195-8
doi: 10.1016/j.athoracsur.2019.12.072
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1663-1669

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Toshihiro Okamoto (T)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio; Transplant Center, Cleveland Clinic, Cleveland, Ohio.

Mohamed Omara (M)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Usman Ahmad (U)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

James Yun (J)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Alejandro Bribriesco (A)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Shinya Unai (S)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Ahmad Zeeshan (A)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Douglas Johnston (D)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Hiromichi Niikawa (H)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio.

Eugene H Blackstone (EH)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio.

Marie Budev (M)

Department of Respiratory Medicine, Lerner Research Institute, Cleveland, Ohio; Transplant Center, Cleveland Clinic, Cleveland, Ohio.

Kenneth R McCurry (KR)

Department of Thoracic and Cardiovascular Surgery, Lerner Research Institute, Cleveland, Ohio; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio; Transplant Center, Cleveland Clinic, Cleveland, Ohio. Electronic address: mccurrk@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH